HOME Top Market Reports Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020

Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020

By: marketsandmarkets.com
Publishing Date: October 2015
Report Code: MD 3842

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


This report studies the global continuous renal replacement therapy market over the forecast period of 2015 to 2020. The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020. Increasing prevalence of AKI, rising adoption of CRRT for the treatment of hemodynamically unstable patients, growing number of ICU patients, growing aging population, clinical advantages of CRRT over intermittent blood purification techniques, and technological advancements in CRRT systems are the key factors fueling the growth of the continuous renal replacement therapy market. However, the high complexity and procedural costs of CRRT, stringent regulatory guidelines for CRRT in North America, and a dearth of trained ICU nurses are hampering market growth. Furthermore, the poor reimbursement scenario in developing countries, a lack of substantial clinical evidence supporting the efficacy of CRRT, and inadequacy of currently approved CRRT technology are the key challenges faced by market players. Emerging markets such as India, China, and Brazil; the broadening application horizons of CRRT; and the development of a continuous renal replacement therapy system for pediatric patients are areas of opportunity for key players in the global continuous renal replacement therapy market.

Emerging markets, including China, India, Brazil, and Mexico, are new revenue pockets for companies in this market. In these markets, the demand for CRRT products is driven by the increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and rising incidences of AKI cases.

As of 2014, Baxter International Inc. (U.S.) held the leadership in continuous renal replacement therapy market. Other key players are Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), Fresenius Medical Care AG & Co. KGaA (Germany), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan). Companies focus on product approvals, launches, & enhancements; acquisition, geographic expansion, and partnerships & agreements as key business strategies to strengthen their presence in the market.

Scope of the Report

This report categorizes the global continuous renal replacement therapy market into the following segments and subsegments:

Market, by Product

  • CRRT Systems
  • CRRT Disposables
  • Hemofilters
  • Bloodlines
  • Other Disposables
  • Dialysate and Replacement Fluids

Market, by Modality

  • Slow Continuous Ultrafiltration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 37)
    4.1 Market Potential
    4.2 Market Opportunity
    4.3 CRRT Market, By Product and Modality (2015 vs 2020)
    4.4 CRRT Market, By Modality (2015)
    4.5 CRRT Market, By Country (2015 vs 2020)

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product
           5.2.2 By Modality
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Prevalence of AKI
                    5.3.1.2 Rising Adoption of CRRT for the Treatment of Renal Disorders
                    5.3.1.3 Growing Number of Icu Patients
                    5.3.1.4 Rapid Rise in Aging Population
                    5.3.1.5 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
                    5.3.1.6 CRRT is A Gold Standard for Treatment of Hemodynamically Unstable Patients
                    5.3.1.7 Technological Advancements and New Product Launches
                    5.3.1.8 Increasing Prevalence of Sepsis
           5.3.2 Restraints
                    5.3.2.1 High Complexity of Therapy
                               5.3.2.1.1 Lack of Standard Treatment Guidelines
                               5.3.2.1.2 Complications Associated With CRRT
                    5.3.2.2 High Procedural Cost of CRRT
                    5.3.2.3 Stringent Regulatory Guidelines for CRRT in North America
                    5.3.2.4 Dearth of Trained Icu Nurses
           5.3.3 Opportunities
                    5.3.3.1 Emerging Markets
                    5.3.3.2 Broadening Application Horizon of CRRT
                               5.3.3.2.1 Evolution of CRRT From Simple Renal Replacement Treatment to A Multi-Organ Support Therapy (Most)
                               5.3.3.2.2 CRRT: Progression From Adaptive Renal Devices to Multipurpose Treatment Machines
                    5.3.3.3 Ongoing Researches to Establish Safety and Efficacy Profile of CRRT
                    5.3.3.4 Development of A CRRT System for Pediatric Patients
                               5.3.3.4.1 the Carpediem Project
                    5.3.3.5 Untapped Market Growth Opportunities in North America
           5.3.4 Challenges
                    5.3.4.1 Poor Reimbursement Scenario in Developing Countries
                    5.3.4.2 Lack of Substantial Clinical Evidences Supporting Efficacy of CRRT
                    5.3.4.3 Currently Approved CRRT Technology is Inadequate for Children
                    5.3.4.4 Lack of Awareness About the Benefits of CRRT
           5.3.5 Winning Imperatives
                    5.3.5.1 Selling Machines Along With Disposables to End Users.
                    5.3.5.2 High Bargaining Margins on Disposables as Well as Machines
                    5.3.5.3 Development of CRRT Machine That is Only Compatible With Respective Companyís Disposables
                    5.3.5.4 Core Competency of Players
           5.3.6 Industry Trends
                    5.3.6.1 Training Programs for the Operation of CRRT Devices
                    5.3.6.2 Rising Adoption of User-Friendly CRRT Machines

6 Industry Insights (Page No. - 59)
    6.1 Introduction
    6.2 Reimbursement Scenario
           6.2.1 North America
           6.2.2 Europe
           6.2.3 Asia-Pacific (Excluding Japan)
           6.2.4 Japan
           6.2.5 Rest of the World
    6.3 Regulatory Landscape
           6.3.1 North America
           6.3.2 Europe
           6.3.3 Asia-Pacific
           6.3.4 Rest of the World
    6.4 Porterís Five Forces Analysis
           6.4.1 Competitive Intensity
           6.4.2 Bargaining Power of Buyers
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Threat of Substitutes
           6.4.5 Threat of New Entrants
    6.5 Pricing and Cost Analysis
    6.6 Strategic Recommendations
           6.6.1 Design Recommendations for CRRT Machines
           6.6.2 Key Strategies for Players Seeking to Enter the CRRT Market

7 Adoption of CRRT, By Region (Page No. - 70)
    7.1 Introduction
    7.2 Utilization of CRRT Procedures, By Region
    7.3 Number of CRRT Patients, By Region

8 CRRT Market, By Product (Page No. - 74)
    8.1 Introduction
           8.1.1 Dialysate and Replacement Fluids
           8.1.2 CRRT Disposables
                    8.1.2.1 Hemofilters
                    8.1.2.2 Bloodline Sets (Tubing Sets)
                    8.1.2.3 Other Disposables
           8.1.3 CRRT Systems

9 CRRT Market, By Modality (Page No. - 85)
    9.1 Introduction
    9.2 Continuous Venovenous Hemofiltration (CVVH)
    9.3 Continuous Venovenous Hemodiafiltration (CVVHDF)
    9.4 Continuous Venovenous Hemodialysis (CVVHD)
    9.5 Slow-Continuous Ultrafiltration (SCUF)

10 CRRT Market, By Region (Page No. - 96)
     10.1 Introduction
     10.2 CRRT Market, By Region
             10.2.1 Europe
                        10.2.1.1 CRRT Machines Approved for Multiple Applications
                        10.2.1.2 Intensivistsí Preference for CRRT for AKI Treatment
                        10.2.1.3 Players Focus on Leveraging Growth Opportunities in Europe
                        10.2.1.4 Germany
                                     10.2.1.4.1 Rising Focus of Players on the German CRRT Market
                        10.2.1.5 U.K.
                                     10.2.1.5.1 Rising Awareness About AKI in U.K.
                        10.2.1.6 France
                                     10.2.1.6.1 Symposia and Conferences
                        10.2.1.7 Rest of Europe
                                     10.2.1.7.1 Clinical Research and Trials Driving Market Growth in Roe
             10.2.2 North America
                        10.2.2.1 North American Utilization of CRRT Lower Than That of Europe, Australia, and Japan
                        10.2.2.2 Regulatory Policies, A Key Hindrance to Market Growth
                        10.2.2.3 U.S.
                                     10.2.2.3.1 Prevalence of AKI, Esrd Rising Due to Growth in Aging Population
                                     10.2.2.3.2 Technological Advancement to Boost Demand for CRRT Products
                                     10.2.2.3.3 Ongoing Clinical Trials to Prove Safety and Efficacy of CRRT Products
                                     10.2.2.3.4 Government Funding & Grants to Develop Cost-Effective Treatments for AKI Patients
                                     10.2.2.3.5 Shortage of Registered Nurses in Icu Settings
                        10.2.2.4 Canada
                                     10.2.2.4.1 Rising AKI Prevalence
                                     10.2.2.4.2 Barriers to Enter the Canadian CRRT Market
                                     10.2.2.4.3 High Costs of CRRT as Compared to Ihd
             10.2.3 Asia-Pacific
                        10.2.3.1 High Use of CRRT in Australia and Japan
                        10.2.3.2 Studies and Clinical Trials to Establish the Safety and Efficacy Profile of CRRT
                        10.2.3.3 Dearth of Reimbursement and Technical Expertise
                        10.2.3.4 Japan
                                     10.2.3.4.1 Japan Focusing on the Use of CRRT for Non-Renal Indications
                                     10.2.3.4.2 Large Number of Domestic Manufacturers - A Barrier to the Entry of Major Players
                        10.2.3.5 China
                                     10.2.3.5.1 Rising Incidence of AKI and Esrd in the China
                        10.2.3.6 India
                        10.2.3.7 Rest of Asia-Pacific
                                     10.2.3.7.1 High Utilization of CRRT in Australia
             10.2.4 Rest of the World (RoW)
                        10.2.4.1 South Africa
                        10.2.4.2 Latin America and the Middle East

11 Competitive Intelligence Analysis (Page No. - 131)
     11.1 Competitive Intensity
             11.1.1 Evaluation Parameters and Scores
             11.1.2 Scoring Methodology
             11.1.3 Competitive Intensity Score, By Company
                        11.1.3.1 Baxter International Inc.
                        11.1.3.2 Nxstage Medical, Inc.
                        11.1.3.3 B. Braun Melsungen AG
                        11.1.3.4 Fresenius Medical Care AG & Co. KGAA
             11.1.4 Competitive Intensity - Mapping of Baxter, Nxstage, B.Braun, and Fresenius
             11.1.5 Market Share Analysis
                        11.1.5.1 Baxter International Inc.
                        11.1.5.2 Fresenius Medical Care AG & Co. KGAA
                        11.1.5.3 Nxstage Medical, Inc.
     11.2 Competitive Situation and Trends
             11.2.1 Product Approvals, Launches, and Enhancements
             11.2.2 Expansions
             11.2.3 Acquisitions
             11.2.4 Agreements, Partnerships, and Collaborations

12 Company Profiles (Page No. - 144)
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View)*
     12.1 Introduction
     12.2 Baxter International Inc.
     12.3 Fresenius Medical Care AG & Co. KGAA
     12.4 Nikkiso Co., Ltd.
     12.5 B. Braun Melsungen AG
     12.6 Nxstage Medical, Inc.
     12.7 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
     12.8 Bellco S.R.L.
     12.9 Infomed SA
     12.10 Medica S.P.A
     12.11 Medical Components, Inc.
     12.12 Toray Medical Company Limited

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 165)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (76 Tables)

Table 1 Use of CRRT as A Gold Standard for Treatment of Hemodynamically Unstable Patients is Driving Market Growth
Table 2 High Procedural Cost of CRRT Restraining the Market Growth
Table 3 Evolution of CRRT From Simple Renal Replacement Treatment to Multipurpose Therapy Unfolds New Growth Opportunities
Table 4 Lack of Substantial Clinical Evidences Supporting Efficacy of CRRT Poses A Key Challenge for the Market
Table 5 Average Selling Price (Asp) of CRRT Machines, By Manufacturer, 2014
Table 6 Average Selling Price of CRRT Bloodlines and Dialysate Bags, 2014
Table 7 Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 8 Continuous Renal Replacement Therapy Dialysate & Replacement Fluids Market Size, By Region, 2013-2020 (USD Million)
Table 9 Europe: CRRT Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 10 North America: CRRT Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 11 Asia-Pacific: CRRT Dialysate & Replacement Fluids Market Size, By Country, 2013-2020 (USD Million)
Table 12 Continuous Renal Replacement Therapy Market Size, By Disposables, 2013-2020 (USD Million)
Table 13 CRRT Disposables Market Size, By Region, 2013-2020 (USD Million)
Table 14 Europe: CRRT Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 15 North America: CRRT Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 16 Asia-Pacific: CRRT Disposables Market Size, By Country, 2013-2020 (USD Million)
Table 17 CRRT Systems Market Size, By Region, 2013-2020 (USD Million)
Table 18 Europe: CRRT Systems Market Size, By Country, 2013-2020 (USD Million)
Table 19 North America: CRRT Systems Market Size, By Country, 2013-2020 (USD Million)
Table 20 Asia-Pacific: CRRT Systems Market Size, By Country, 2013-2020 (USD Million)
Table 21 Continuous Renal Replacement Therapy Market Size, By Modality, 2013-2020 (USD Million)
Table 22 Continuous Renal Replacement Therapy Market Size for CVVH, By Region, 2013-2020 (USD Million)
Table 23 North America: Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 24 Europe: CRRT Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 25 Asia-Pacific: CRRT Market Size for CVVH, By Country, 2013-2020 (USD Million)
Table 26 CRRT Market Size for CVVHDF, By Region, 2013-2020 (USD Million)
Table 27 North America: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 28 Europe: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 29 Asia-Pacific: CRRT Market Size for CVVHDF, By Country, 2013-2020 (USD Million)
Table 30 CRRT Market Size for CVVHD, By Region, 2013-2020 (USD Million)
Table 31 North America: CRRT Market Size for CVVHD, By Country, 2013-2020 (USD Million)
Table 32 Europe: CRRT Market Size for CVVHD, By Country, 2013-2020 (USD Million)
Table 33 Asia-Pacific: CRRT Market Size for CVVHD, By Country, 2013-2020 (USD Million)
Table 34 CRRT Market Size for SCUF, By Region, 2013-2020 (USD Million)
Table 35 North America: CRRT Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 36 Europe: CRRT Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 37 Asia-Pacific: CRRT Market Size for SCUF, By Country, 2013-2020 (USD Million)
Table 38 Continuous Renal Replacement Therapy Market Size, By Region, 2013-2020 (USD Million)
Table 39 Europe: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 40 Europe: CRRT Products Market Size, By Country, 2013-2020 (USD Million)
Table 41 Europe: Market Size, By Modality, 2013-2020 (USD Million)
Table 42 Europe: CRRT Modalities Market Size, By Country, 2013-2020 (USD Million)
Table 43 Germany: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 44 Germany: Market Size, By Modality, 2013-2020 (USD Million)
Table 45 U.K.: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 46 U.K.: Market Size, By Modality, 2013-2020 (USD Million)
Table 47 France: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 48 France: Market Size, By Modality, 2013-2020 (USD Million)
Table 49 Rest of Europe: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 50 Rest of Europe: Market Size, By Modality, 2013-2020 (USD Million)
Table 51 North America: Market Size, By Product, 2013-2020 (USD Million)
Table 52 North America: CRRT Products Market Size, By Country, 2013-2020 (USD Million)
Table 53 North America: Market Size, By Modality, 2013-2020 (USD Million)
Table 54 North America: CRRT Modalities Market Size, By Country, 2013-2020 (USD Million)
Table 55 U.S.: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 56 U.S.: Market Size, By Modality, 2013-2020 (USD Million)
Table 57 Canada: CRRT Market Size, By Product, 2013-2020 (USD Million)
Table 58 Canada: Market Size, By Modality, 2013-2020 (USD Million)
Table 59 Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 60 Asia-Pacific: Market Size for Products, By Country, 2013-2020 (USD Million)
Table 61 Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Modality, 2013-2020 (USD Million)
Table 62 Asia-Pacific: Continuous Renal Replacement Therapy Modalities Market Size, By Country, 2013-2020 (USD Million)
Table 63 Japan: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 64 Japan: Market Size, By Modality, 2013-2020 (USD Million)
Table 65 China: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 66 China: Market Size, By Modality, 2013-2020 (USD Million)
Table 67 India: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 68 India: Market Size, By Modality, 2013-2020 (USD Million)
Table 69 Rest of Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 70 Rest of Asia-Pacific: Continuous Renal Replacement Therapy Market Size, By Modality, 2013-2020 (USD Million)
Table 71 RoW: Continuous Renal Replacement Therapy Market Size, By Product, 2013-2020 (USD Million)
Table 72 RoW: Market Size, By Modality, 2013-2020 (USD Million)
Table 73 Product Approvals, Launches, and Enhancements, 2012-2015
Table 74 Expansions, 2012-2015
Table 75 Acquisitions, 2012-2015
Table 76 Agreements, Partnerships, and Collaborations, 2012-2015

List of Figures (66 Figures)

Figure 1 Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Supply Side
Figure 4 Demand Side
Figure 5 Estimation of Continuous Renal Replacement Therapy Procedural Volume
Figure 6 Research Methodology: Top-Down Approach {For Market Size Estimation of Disposables (Bloodline Sets, Hemofilters, and Water Bags)}
Figure 7 Research Methodology: Top-Down Approach (For Market-Size Estimation of CRRT Machines)
Figure 8 Research Methodology: Bottom-Up Approach
Figure 9 Research Design
Figure 10 Data Triangulation Steps (Top-Down and Bottom-Up Approaches)
Figure 11 Data Triangulation Methodology
Figure 12 Market Segmentation
Figure 13 Europe to Command the Largest Share of the Overall Continuous Renal Replacement Therapy Market in 2015
Figure 14 Hemofilters to Form the Largest Segment of CRRT Disposables Market in 2015
Figure 15 CVVHDF is Poised to Be the Fastest-Growing Segment During 2015-2020
Figure 16 Asia-Pacific is Poised to Grow at the Highest Growth Rate in the Forecast Period
Figure 17 Baxter Will Continue to Dominate the Global CRRT Market During Forecast Period
Figure 18 High Potential and Applications of CRRT to Increase Its Share in the High-Margin AKI Market
Figure 19 Market Growth Will Be Driven By the Rising Prevalence of AKI
Figure 20 Dialysate & Replacement Fluids Product Segment and CVVH Modality Segment Will Dominate the CRRT Market
Figure 21 CVVH Dominates the Asia-Pacific CRRT Market in 2015
Figure 22 U.S. to Dominate Global CRRT Market in the Next Five Years
Figure 23 Continuous Renal Replacement Therapy Market Segmentation
Figure 24 CRRT Market Segmentation, By Product
Figure 25 CRRT Market Segmentation, By Modality
Figure 26 Continuous Renal Replacement Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 27 CRRT Market is Expected to Grow Inline With Rising Prevalence of AKI
Figure 28 Rise in Global Adoption of CRRT for the Treatment of AKI
Figure 29 Key Factors Affecting Reimbursement Rates for CRRT Procedures
Figure 30 Reimbursement Scenario of CRRT in 2015
Figure 31 Reimbursement Structures Vary Widely Across Europe
Figure 32 Key Regulatory Bodies Involved in the Approval of New CRRT Products
Figure 33 Porterís Five Forces Analysis Ė Global Continuous Renal Replacement Therapy Market
Figure 34 Design Recommendations for CRRT Machines
Figure 35 Utilization of CRRT and Dialysis for the Treatment of Renal Patients in Icu, By Region (2014)
Figure 36 Rate of Switching From CRRT to IHD, By Region, 2014
Figure 37 Number of CRRT Patients Across the Globe, 2014
Figure 38 Europe Will Dominate the Overall CRRT Market (2015 vs 2020)
Figure 39 Disposables Form the Fastest-Growing Business Within the Global CRRT Industry
Figure 40 Hemofilters to Dominate the CRRT Disposables Market During Forecast Period
Figure 41 Types of Continuous Renal Replacement Therapy Modalities
Figure 42 CVVHDF Segment to Grow at the Highest CAGR in the Forecast Period
Figure 43 Europe to Dominate the Overall CVVH Market During Forecast Period
Figure 44 Europe is Estimated to Account for the Major Share of the Total CVVHDF Market in 2015
Figure 45 Growth in AKI Cases Worldwide (2010 -2020)
Figure 46 Europe Will Dominate the Overall Continuous Renal Replacement Therapy Market in the Forecast Period
Figure 47 The U.S. Will Be the Major Contributor to the Global CRRT Market in the Forecast Period
Figure 48 European Continuous Renal Replacement Therapy Market Snapshot: Germany Will Continue to Dominate the Market in the Forecast Period
Figure 49 Germany to Drive the Growth of Continuous Renal Replacement Therapy Market in Europe
Figure 50 CVVH Accounted for the Major Share of the European Continuous Renal Replacement Therapy Market in 2015
Figure 51 North American Continuous Renal Replacement Therapy Market Snapshot: U.S. Will Be the Major Contributor to Market Growth in the Forecast Period
Figure 52 Asia-Pacific CRRT Market Snapshot: China Will Be the Fastest-Growing Country in the Region
Figure 53 China Will Be the Fastest-Growing Country in the Asia-Pacific CRRT Market in the Forecast Period
Figure 54 Dialysate & Replacement Fluids Segment Accounts for the Major Share of the RoW CRRT Market, By Product, in 2015
Figure 55 Scoring Methodology
Figure 56 Comparison of Competitive Intensity Scores: Baxter, Nxstage,B.Braun, and Fresenius
Figure 57 Relative Positioning of Companies Based on Competitive Intensity Score and CRRT Focus
Figure 58 Global CRRT Products Market Share Analysis, By Key Player, 2014
Figure 59 Geographical Presence of Key Players in Continuous Renal Replacement Therapy Market, 2014
Figure 60 Baxter International Inc.: Company Snapshot
Figure 61 Fresenius Medical Care AG & Co. KGAA: Company Snapshot
Figure 62 Nikkiso Co., Ltd.: Company Snapshot
Figure 63 B. Braun Melsungen AG: Company Snapshot
Figure 64 Nxstage Medical, Inc.: Company Snapshot
Figure 65 Asahi Kasei Corporation: Company Snapshot
Figure 66 Toray Group: Company Snapshot

On the basis of products, the continuous renal replacement therapy market is classified into CRRT systems, CRRT disposables, and dialysate and replacements fluids. The CRRT disposables segment is further divided into hemofilters, bloodlines, and other disposables. The CRRT dialysate and replacement fluids segment is expected to account for the largest share of the global market in 2015. This high share of dialysate and replacement fluids segment in the global market is primarily attributed to the high volume requirements of replacement and dialysate fluids during a CRRT procedure as well as the development and commercialization of advanced renal replacement solutions (in terms of safety and efficacy).

On the basis of modality, the continuous renal replacement therapy market is categorized into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The CVVH segment is expected to account for the largest share of the market in 2015. This is primarily attributed to the high filtrate flow in CVVH that enhances the performance of solute removal. The CVVHDF segment is expected to grow at the highest CAGR in the next five years, owing to the capability of this technology to ensure the better clearance of medium-sized solutes as compared to hemodialysis.

This report studies the global continuous renal replacement therapy market over the forecast period of 2015 to 2020. The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020. A number of factors such as the rising prevalence of AKI, increasing prevalence of sepsis, growing number of ICU patients, clinical advantages of CRRT over intermittent blood purification techniques, technological advancements in CRRT systems, and the preference for CRRT (it is held as the gold standard for the treatment of hemodynamically unstable patients) are propelling the growth of the CRRT market. However, the high complexity of therapy, high procedural cost of CRRT, dearth of trained ICU nurses, and stringent and regulatory guidelines for CRRT in North America are factors restraining the growth of this market. Poor reimbursement scenarios in developing nations, a lack of substantial clinical evidence supporting the efficacy of CRRT, and inadequacy of currently approved CRRT technology for children are the key challenges faced by market players in the continuous renal replacement therapy market.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, the global continuous renal replacement therapy market is expected to be dominated by Europe. The increasing cases of AKI in Europe with rising aging population, approvals for CRRT machines as well as anti-coagulating agents in Europe for multiple applications, high utilization rate of continuous renal replacement therapy products in Europe, prescription of CRRT products by intensivists in Europe, and research studies and controlled clinical trials to obtain the efficacy and safety profile of CRRT products are driving the growth of the market in this region. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020 due to factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and growing incidences of AKI cases in this region.

Product approvals, launches, and enhancements are the key strategies adopted by major players to strengthen their positions in the global continuous renal replacement therapy market. Moreover, strategies such as acquisition, expansion, and agreements, partnerships, and collaborations were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.

Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Bellco S.r.l. (Italy), Fresenius Medical Care AG & Co. KGaA (Germany), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan) are the key players operating in the global continuous renal replacement therapy market.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo